跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ARIPIPRAZOLE
Authorized
STANDARD
ARIPIPRAZOLE
SANIS HEALTH INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
d14de267a4ca1cde
Company
SANIS HEALTH INC
Type
Standard
Approval Details
Approval Id
d14de267a4ca1cde
Drug Approval Canada Name
ARIPIPRAZOLE
Product Name
ARIPIPRAZOLE
Status
Marketed
Status Date
2021-04-23
Original Market Date
2021-04-23
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
28:16.08.04
Atc Original
N05AX12 ARIPIPRAZOLE
Aig Number
0152514005
Company Name
SANIS HEALTH INC
Company Address
1 Presidents Choice Circle Brampton Ontario Canada L6Y 5S5
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
d14de267a4ca1cde
Type
Standard
Back to Health Canada Approvals